12,000 diabetes records put kidney risk under the microscope

NCT ID NCT07818434

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are examining the medical records of 12,000 people with type 2 diabetes who visited a large diabetes care center in Southern India during 2022 and 2023. The study aims to estimate how many of these patients have kidney insufficiency, a complication that past estimates have placed at widely different levels. The team will also look at whether age, gender, body mass index, blood sugar control, and high blood pressure relate to kidney problems. This is a retrospective study, meaning it analyzes existing data rather than testing a treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study maps how common kidney insufficiency is in this group, it could help clinics in Southern India spot kidney problems earlier in people with type 2 diabetes.
What could go wrong
This study looks back at existing records from one diabetes center, so its numbers may not apply to other regions or health systems. It cannot prove what causes kidney insufficiency, only describe patterns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

12,000 people

The number who actually took part.

Started

Feb 2022

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who had visited the Diabetes care centre during the study period.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Type 2 diabetes patients who attended the outpatient department of the hospital during 2022 and 2023 will be included in the study. Exclusion Criteria Type 1 Diabetes and other forms. .

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic kidney disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr.A.Ramachandrans'S Diabetes Hospitals

    Chennai, Tamil Nadu, 600032, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.